04.30.13
NextBio and Sanofi have entered a multi-year collaboration for the use of NextBio’s data integration platform to incorporate patient omics and clinical data into Sanofi's R&D as part of its Translational Medicine for Patients (TM4P) program.
The NextBio Clinical platform provides aggregation, standardization and analysis of patient clinical data, next generation sequencing (NGS) and other molecular data across public data sources, Sanofi clinical trials and Sanofi hospital partners. NextBio's data integration platform, user interface and real-time Big Data analytics will be used to help Sanofi extract a vast collection of patient data as it becomes available, and as a key enabling technology for translational and clinical research.
"Sanofi has long used NextBio as an important component of the company's preclinical research programs," said Saeid Akhtari, president and chief executive officer of NextBio. "The new translational medicine partnership with NextBio, with its Big Data Genomics capabilities, will enable Sanofi to implement patient-centered approaches across all stages of translational and clinical research in several major therapeutic areas, including oncology and diabetes."
The NextBio Clinical platform provides aggregation, standardization and analysis of patient clinical data, next generation sequencing (NGS) and other molecular data across public data sources, Sanofi clinical trials and Sanofi hospital partners. NextBio's data integration platform, user interface and real-time Big Data analytics will be used to help Sanofi extract a vast collection of patient data as it becomes available, and as a key enabling technology for translational and clinical research.
"Sanofi has long used NextBio as an important component of the company's preclinical research programs," said Saeid Akhtari, president and chief executive officer of NextBio. "The new translational medicine partnership with NextBio, with its Big Data Genomics capabilities, will enable Sanofi to implement patient-centered approaches across all stages of translational and clinical research in several major therapeutic areas, including oncology and diabetes."